The NCI Outstanding Investigator Award (OIA) supports investigators with outstanding records of cancer research accomplishments by providing extended funding stability and encouraging investigators to continue or embark on a research program of unusual potential in cancer. The OIA provides up to $600,000 in direct costs per year for 7 years, allowing substantial time for funded investigators to take greater risks and be more adventurous in their research.
Candidates for the OIA must be nominated by their applicant organization which should consider nominating meritorious mid-career, women and under-represented minority candidates. Additional eligibility criteria can be found in RFA-CA-22-045 under Eligible Individuals (Program Director/Principal Investigator).
The Outstanding Investigator Award (R35)
NCI established the Outstanding Investigator Award (R35) in 2014 for principal investigators who have achieved significant research accomplishments. Featured in this video is Holly Prigerson, Ph.D., of Weill Cornell Medicine, who is among the first group of 62 researchers to receive the award.